ENTO   $0.5899  -4.85% Market Closed After Close 0.5987 1.49%

Entero Therapeutics Inc
Total Cash 662.48K
totalCashPerShare 0.139
EBITDA -19.99M
Total Debt 356.03K
quickRatio 0.043
currentRatio 5.485
Total Revenue
debtToEquity 0.503
Revenue/Share
ROA -0.27661
ROE -0.26393998
grossProfits
freeCashflow -77.05M
operatingCashflow -13.97M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 64.65M
forwardPE -0.4526316
floatShares 4.65M
sharesOutstanding 4.75M
sharesShort 295.78K
sharesShortPriorMonth 127.32K
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.03%
Short Ratio help_outline 0.42%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 3.101
Price To Book help_outline 0.22
earningsQuarterlyGrowth
netIncomeToCommon -9.69M
trailingEps 13.06%
forwardEps -1.52%
enterpriseToEbitda -3.23
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.32 3Q 2024
institutionsCount 8
lastUpdated Nov. 2, 2024, 7:34 a.m.